SFM
ABMD

Signet Financial Management’s Abiomed Inc ABMD Stock Holding History

Signet Financial Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-125
Closed -$51K – 1067
2018
Q2 		$51K Buy
+125
New +$45.3K 0.01% 392

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Signet Financial Management's ABMD Position: Q3 2018 in Review

Signet Financial Management sold out of Abiomed Inc (ABMD) in Q3 2018, closing a stake of 125 shares — an estimated $51K sold.

Signet Financial Management first reported a position in ABMD in Q2 2018 and held it in 1 quarter. The position peaked at $51K in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q3 2018.

  • Signet Financial Management reported no remaining Abiomed Inc position as of Q3 2018 after selling out during the quarter.
  • Signet Financial Management sold 125 Abiomed Inc shares in Q3 2018, an estimated $51K.
  • Signet Financial Management first reported a position in Abiomed Inc in Q2 2018 and held it in 1 quarter.
  • Signet Financial Management's Abiomed Inc position peaked at $51K in Q2 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2018.

Based on Signet Financial Management's 13F filing for Q3 2018, filed 14 Nov 2018.